Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Am J Infect Control ; 2024 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-38969069

RESUMO

In the United States, the system for special pathogen patient care incorporates a network of federally funded US biocontainment units that maintain operational readiness to care for patients afflicted by high-consequence infectious diseases (HCIDs). This network has expanded in number of facilities and in scope, serving as a regional resource for special pathogen preparedness. Lessons learned for maintaining these units are shared with the intent of informing new and existing biocontainment units.

2.
Health Secur ; 22(1): 65-73, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38241511

RESUMO

Healthcare workers (HCWs) at community hospitals, also known as frontline hospitals (FLHs), may encounter patients with possible infectious diseases, including those caused by high-consequence pathogens such as Zaire ebolavirus. We created and piloted a 1-day, in-person, didactic and skills training program to determine the feasibility and acceptability of implementing an educational program to enhance the knowledge and skills needed to respond when a patient with a potential high-consequence pathogen presents to an FLH. The Maryland Department of Health queried all 104 state FLHs to identify their interest in participating in the pilot training program. HCWs from 12 (75%) of the 16 interested FLHs participated in the program before it was interrupted by the COVID-19 pandemic. In addition to pathogen-specific training based on the Identify, Isolate, and Inform framework, we provided skills training in the proper use of personal protective equipment, spill cleanup, and removal of an incapacitated HCW from an isolation area. We conducted a paired pretraining and posttraining knowledge assessment and measured a significant learning gain among 135 participants (2-tailed t test, P<.05). Over 95% of the participants reported that the training was relevant to their daily work and the clinical simulations and reference material were useful and appropriate for their learning level. Findings from this pilot program demonstrated the feasibility and acceptability of a 1-day combined didactic and skills training program focused on high-consequence pathogens. We plan to reengage the original FLHs and add regional FLHs in an updated training effort based on our findings.


Assuntos
Anormalidades Múltiplas , COVID-19 , Anormalidades Craniofaciais , Transtornos do Crescimento , Comunicação Interventricular , Pandemias , Humanos , Maryland , Pessoal de Saúde , Recursos Humanos em Hospital
3.
Health Secur ; 22(S1): S45-S49, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39037030

RESUMO

Developing and sustaining relationships and networks before an emergency occurs is crucial. The Biocontainment Unit Leadership Workgroup is a consortium of the 13 Regional Emerging Special Pathogen Treatment Centers in the United States. Established in 2017, the volunteer-based workgroup is composed of operational leaders dedicated to maintaining readiness for special pathogen care. Monthly meetings focus on addressing operational challenges, sharing best practices, and brainstorming solutions to common problems. Task forces are leveraged to tackle more complex issues that are identified as priorities. In 2022, members of the workgroup were harnessed for response efforts related to mpox, Sudan ebolavirus, and Marburg virus disease. The weekly Outbreak Readiness call is a shared effort between the Biocontainment Unit Leadership Workgroup and the Special Pathogens Research Network of the National Emerging Special Pathogens Training and Education Center. Call participants included leaders of the Regional Emerging Special Pathogen Treatment Centers and federal partners who shared weekly updates on operational readiness of units, case counts, laboratory capacity, available medical countermeasures, and other pertinent information. The routine exchange of real-time information enabled learning and collegial sharing of experiences, highlighted the experience of the network to federal partners, and provided situational awareness of special pathogen outbreaks across the country. The consortium enabled this rapid convening of partners to meet an urgent need for special pathogen response. The weekly Outbreak Readiness call is a communication model and scalable framework that serves both domestic preparedness efforts and international efforts should the need for a collaborative global response arise. In this case study, we describe the framework and experience of this partnership, along with the structure of rapid deployment for group convening.


Assuntos
Surtos de Doenças , Doença pelo Vírus Ebola , Liderança , Humanos , Surtos de Doenças/prevenção & controle , Doença pelo Vírus Ebola/prevenção & controle , Doença pelo Vírus Ebola/epidemiologia , Estados Unidos , Contenção de Riscos Biológicos/métodos , Doença do Vírus de Marburg/prevenção & controle
4.
Health Secur ; 22(S1): S50-S65, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39212633

RESUMO

Infectious disease physicians in England have been diagnosing and managing occasional cases of viral hemorrhagic fever since 1971, including the United Kingdom's first case of Ebola virus disease in 1976. Specialist isolation facilities to provide safe and effective care have been present since that time. Following the emergence of Middle East respiratory syndrome (MERS) in 2012, and the avian influenza A (H7N9) outbreak in 2013, and the 2014-2016 Ebola virus disease outbreak in West Africa, clinical and public health preparedness and response pathways in England have been strengthened for these types of diseases, now called high-consequence infectious diseases (HCIDs). The HCID program, led by NHS England and Public Health England between 2016 and 2018, helped to deliver these enhancements, which have since been used on multiple occasions for new UK cases and outbreaks of MERS, mpox, avian influenza, and Lassa fever. Additionally, HCID pathways were activated for COVID-19 during the first 3 months of 2020, before the pandemic had been declared and little was known about COVID-19 but HCID status had been assigned temporarily to COVID-19 as a precaution. The HCID program also led to the commissioning of a network of new airborne HCID treatment centers in England, to supplement the existing network of contact HCID treatment centers, which includes the United Kingdom's only 2 high-level isolation units. In this case study, the authors describe the airborne and contact HCID treatment center networks in England, including their formation and structures, their approach to safe and effective clinical management of patients with HCIDs in the United Kingdom, and challenges they may face going forward.


Assuntos
Controle de Doenças Transmissíveis , Doenças Transmissíveis , Surtos de Doenças , Humanos , Controle de Doenças Transmissíveis/organização & administração , Controle de Doenças Transmissíveis/métodos , Doenças Transmissíveis/epidemiologia , Doenças Transmissíveis/terapia , Surtos de Doenças/prevenção & controle , Inglaterra/epidemiologia , Hospitalização
5.
Open Forum Infect Dis ; 10(4): ofad152, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37035492

RESUMO

In November 2022, the National Emerging Special Pathogens Training and Education Center hosted a virtual session with global high-level isolation unit (HLIU) representatives to discuss HLIU staffing challenges and approaches. Takeaways are relevant to healthcare institutions seeking solutions to recruit and retain their healthcare workforce amid unprecedented global staffing shortages.

6.
Health Secur ; 20(S1): S20-S30, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35483093

RESUMO

The need for well-controlled clinical trials is fundamental to advancing medicine. Care should be taken to maintain high standards in trial design and conduct even during emergency medical events such as an infectious disease outbreak. In 2020, SARS-CoV-2 emerged and rapidly impacted populations around the globe. The need for effective therapeutics was immediately evident, prompting the National Institutes of Health to initiate the Adaptive COVID-19 Treatment Trial. The Special Pathogens Research Network, made up of 10 Regional Emerging Special Pathogens Treatment Centers, was approached to participate in this trial and readily joined the trial on short notice. By trial closure, the Special Pathogens Research Network sites, making up 19% of all study sites, enrolled 26% of the total participants. The initial resources available and experience in running clinical trials at each treatment center varied from minimal experience and few staff to extensive experience and a large staff. Based on experiences during the first phase of this trial, the Special Pathogens Research Network members provided feedback regarding operational lessons learned and recommendations for conducting future studies during a pandemic. Communication, collaboration, information technology, regulatory processes, and access to resources were identified as important topics to address. Key stakeholders including institutions, institutional review boards, and study personnel must maintain routine communication to efficiently and effectively activate when future research needs arise. Regular and standardized training for new personnel will aid in transitions and project continuity, especially in a rapidly evolving environment. Trainings should include local just-in-time training for new staff and sponsor-designed modules to refresh current staff knowledge. We offer recommendations that can be used by institutions and sponsors to determine goals and needs when preparing to set up this type of trial for critical, short-notice needs.


Assuntos
Tratamento Farmacológico da COVID-19 , Humanos , National Institute of Allergy and Infectious Diseases (U.S.) , Pandemias/prevenção & controle , SARS-CoV-2 , Estados Unidos
7.
Health Secur ; 20(S1): S39-S48, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35587214

RESUMO

Infectious disease outbreaks and pandemics have repeatedly threatened public health and have severely strained healthcare delivery systems throughout the past century. Pathogens causing respiratory illness, such as influenza viruses and coronaviruses, as well as the highly communicable viral hemorrhagic fevers, pose a large threat to the healthcare delivery system in the United States and worldwide. Through the Hospital Preparedness Program, within the US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, a nationwide Regional Ebola Treatment Network (RETN) was developed, building upon a state- and jurisdiction-based tiered hospital approach. This network, spearheaded by the National Emerging Special Pathogens Training and Education Center, developed a conceptual framework and plan for the evolution of the RETN into the National Special Pathogen System of Care (NSPS). Building the NSPS strategy involved reviewing the literature and the initial framework used in forming the RETN and conducting an extensive stakeholder engagement process to identify gaps and develop solutions. From this, the NSPS strategy and implementation plan were formed. The resulting NSPS strategy is an ambitious but critical effort that will have impacts on the mitigation efforts of special pathogen threats for years to come.


Assuntos
Infecções por Coronavirus , Doença pelo Vírus Ebola , Infecções por Coronavirus/epidemiologia , Surtos de Doenças/prevenção & controle , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/prevenção & controle , Humanos , Pandemias , Saúde Pública , Estados Unidos
8.
Health Secur ; 20(S1): S4-S12, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35483049

RESUMO

The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States. Through NETEC, a collaborative network of 10 Regional Emerging Special Pathogen Treatment Centers (RESPTCs) undertook readiness activities that included potential respiratory pathogens. These preparations, which took place before the COVID-19 pandemic, established a foundation of readiness that enabled RESPTCs to play a pivotal role in the US COVID-19 pandemic response. As initial COVID-19 cases were detected in the United States, RESPTCs provided essential isolation capacity, supplies, and subject matter expertise that allowed for additional time for healthcare systems to prepare. Through the Special Pathogen Research Network, RESPTCs rapidly enrolled patients into early clinical trials. During periods of high community transmission, RESPTCs provided educational, clinical, and logistical support to a wide range of healthcare and nonhealthcare settings. In this article, we describe how NETEC and the RESPTC network leveraged this foundation of special pathogen readiness to strengthen the national healthcare system's response to the COVID-19 pandemic. NETEC and the RESPTC network have proven to be an effective model that can support the national response to future emerging special pathogens.


Assuntos
COVID-19 , Doença pelo Vírus Ebola , Humanos , Controle de Infecções , Pandemias/prevenção & controle , Isolamento de Pacientes , Estados Unidos/epidemiologia
9.
Health Secur ; 19(2): 209-213, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33351700

RESUMO

Frontline hospitals are at the forefront of all travel-related, emerging and reemerging infectious diseases and special pathogens. Yet, the readiness of frontline hospitals and their ability to identify, isolate, and inform on Ebola and other special pathogens is uncertain. This article addresses the resources necessary to support screening for Ebola and other special pathogens and presents the decision-making algorithm for the transport of patients with high-consequence infectious diseases within the New York City Health + Hospitals integrated healthcare delivery network, which includes 10 frontline hospitals and the Region 2 Ebola and Other Special Pathogen Treatment Center.


Assuntos
Controle de Doenças Transmissíveis/organização & administração , Surtos de Doenças/prevenção & controle , Doença pelo Vírus Ebola/prevenção & controle , Controle de Doenças Transmissíveis/normas , Ebolavirus , Hospitais , Humanos , Controle de Infecções/organização & administração , Cidade de Nova Iorque , Isolamento de Pacientes/organização & administração
10.
Health Secur ; 17(1): 27-34, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30779610

RESUMO

High-consequence pathogens create a unique problem. To provide effective treatment for infected patients while providing safety for the community, a series of 10 high-level isolation units have been created across the country; they are known as Regional Ebola and Special Pathogen Treatment Centers (RESPTCs). The activation of a high-level isolation unit is a highly resource-intensive activity, with effects that ripple across the healthcare system. The incident command system (ICS), a standard tool for command, control, and coordination in domestic emergencies, is a command structure that may be useful in a biocontainment event. A version of this system, the hospital emergency incident command system, provides an adaptable all-hazards approach in healthcare delivery systems. Here we describe its utility in an operational response to safely care for a patient(s) infected with a high-consequence pathogen on a high-level isolation unit. The Johns Hopkins Hospital created a high-level isolation unit to manage the comprehensive and complex needs of patients with high-consequence infectious diseases, including Ebola virus disease. The unique challenges of and opportunities for providing care in this high-level isolation unit led the authors to modify the hospital incident command system model for use during activation. This system has been tested and refined during full-scale functional and tabletop exercises. Lessons learned from the after-action reviews of these exercises led to optimization of the structure and implementation of ICS on the biocontainment unit, including improved job action sheets, designation of physical location of roles, and communication approaches. Overall, the adaptation of ICS for use in the high-level isolation unit setting may be an effective approach to emergency management during an activation.


Assuntos
Contenção de Riscos Biológicos/métodos , Serviços Médicos de Emergência/organização & administração , Doença pelo Vírus Ebola/terapia , Arquitetura Hospitalar/métodos , Controle de Infecções/métodos , Corpo Clínico Hospitalar/educação , Doença pelo Vírus Ebola/transmissão , Sistemas de Comunicação no Hospital , Humanos , Isolamento de Pacientes , Centros de Atenção Terciária
12.
Health Secur ; 17(1): 35-45, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30779607

RESUMO

The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.


Assuntos
Pesquisa Biomédica/métodos , Ebolavirus/patogenicidade , Serviços Médicos de Emergência/organização & administração , Controle de Infecções/métodos , Contramedidas Médicas , África/epidemiologia , Contenção de Riscos Biológicos/métodos , Epidemias/prevenção & controle , Europa (Continente) , Doença pelo Vírus Ebola/epidemiologia , Humanos , Centros de Atenção Terciária , Estados Unidos
13.
Health Secur ; 17(1): 11-17, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30779612

RESUMO

During the outbreak of Ebola virus disease that struck West Africa during 2014-2016, a small handful of expatriate patients were evacuated to specialized high-level containment care units, or biocontainment units, in the United States and Western Europe. Given the lower mortality rate (18% versus 40% for those treated in Africa) among these patients, it is likely that high-level containment care will be used in the future with increasing frequency. It is also likely that children infected with Ebola and other highly hazardous communicable diseases will someday require such care. The National Ebola Training and Education Center convened a pediatric workgroup to consider the unique and problematic issues posed by these potential child patients. We report here the results of those discussions.


Assuntos
Conferências de Consenso como Assunto , Contenção de Riscos Biológicos , Surtos de Doenças/prevenção & controle , Doença pelo Vírus Ebola/terapia , Controle de Infecções/métodos , Pediatria/métodos , África Ocidental , Criança , Europa (Continente) , Humanos , Pais/psicologia , Isolamento de Pacientes/métodos , Estados Unidos
14.
Health Secur ; 16(3): 158-164, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29927342

RESUMO

Infectious disease response, particularly high-consequence acute infectious disease and special pathogen response, requires the coordination of numerous public and private entities to ensure the safety and appropriate care for patients, healthcare and EMS staff, and the public. The Northwest Healthcare Response Network, an independent 501(c)(3) healthcare coalition, has partnered with the local health departments in the Puget Sound area of Washington State to develop a communication and decision-making structure to support coordinated information sharing, patient care, patient transportation, laboratory testing, contact monitoring, and healthcare and EMS staff safety in events involving suspected or diagnosed acute infectious disease patients. The network has developed a comprehensive regional plan and associated tools outlining standard communication practices that include defining who will lead coordinated communications and decision making concerning patient care needs and how all partners will connect during an acute infectious disease response. Over the past 2 years, the network has tested and refined these communication and coordination processes through a facilitated tabletop exercise and a webinar-based functional exercise. These processes can serve as a model to inform the creation of coordinated communications structures for infectious disease response in communities around the country.


Assuntos
Controle de Doenças Transmissíveis/métodos , Comunicação , Tomada de Decisões , Planejamento em Desastres/normas , Defesa Civil/organização & administração , Controle de Doenças Transmissíveis/organização & administração , Comportamento Cooperativo , Planejamento em Desastres/organização & administração , Humanos , Washington
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa